IDSA Top 3

Healthcare-Associated Infections Prevention

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/170589

Contents of this Issue

Navigation

Page 8 of 9

ÎÎEnsure cleaning and disinfection of equipment and the environment (B-III for equipment and B-II for the environment). ÎÎImplement a laboratory-based alert system to provide immediate notification to infection prevention and control and clinical personnel about patients with newly diagnosed CDI (B-III). ÎÎConduct CDI surveillance; analyze and report CDI data (B-III). ÎÎEducate healthcare personnel, housekeeping personnel, and hospital administration about CDI (B-III). ÎÎEducate patients and their families about CDI as appropriate (B-III). ÎÎMeasure compliance with Centers for Disease Control and Prevention or World Health Organization hand-hygiene and contact precaution recommendations (B-III). Special approaches for the prevention of CDI** ÎÎPerform a CDI risk assessment. ÎÎApproaches to minimize C. difficile transmission by healthcare personnel >> Intensify the assessment of compliance with process measures (B-III). >> Perform hand hygiene with soap and water as the preferred method before exiting the room of a patient with CDI (B-III). >> Place patients with diarrhea under contact precautions while C. difficile test results are pending (B-III). >> Prolong the duration of contact precautions after the patient becomes asymptomatic until hospital discharge (B-III). ÎÎApproaches to minimize CDI transmission from the environment >> Assess the adequacy of room cleaning (B-III). >> Use sodium hypochlorite (bleach)-containing cleaning agents for environmental cleaning. Implement a system to coordinate with the housekeeping department if it is determined that sodium hypochlorite is needed for environmental disinfection (B-II). ÎÎApproaches to reduce the risk of CDI acquisition >> Initiate an antimicrobial stewardship program (AII). Approaches that should NOT be considered a routine part of CDI prevention >> Patients without signs or symptoms of CDI should NOT be tested for C. difficile (B-II). >> C. difficile testing should NOT be repeated at the end of successful therapy for a patient recently treated for CDI (B-III). * Recommended for all acute care hospitals. ** These special approaches are recommended for use in locations and/or populations within the hospital for which outcome data and/or risk assessment suggest lack of effective control despite implementation of basic practices.

Articles in this issue

Archives of this issue

view archives of IDSA Top 3 - Healthcare-Associated Infections Prevention